Literature DB >> 20593493

Evidence-based medicine: the time has come to set standards for staging.

Phil Quirke1, Claude Cuvelier, Arzu Ensari, Bengt Glimelius, Søren Laurberg, Hector Ortiz, Francoise Piard, Cornelis J A Punt, Anders Glenthoj, Freddy Pennickx, Matt Seymour, Vincenzo Valentini, Geraint Williams, Iris D Nagtegaal.   

Abstract

For international communication in cancer, staging systems such as TNM are essential; however, the principles and processes used to decide about changes in every new edition of TNM need to be subject to debate. Changes with major impact for patient treatment are introduced without evidence. We think that TNM should be a continual reactive process, rather than a proactive process. Changes should only occur after extensive discussion within the community, and before the introduction of any changes these should be tested for reproducibility and compared to the currently used gold standard. TNM should not be used to test hypotheses. It should introduce established facts that are beneficial to predicting patient prognosis. TNM should thus be restructured on a basis equivalent to evidence-based guidelines. The strength of the evidence should be explicitly stated and the evidence base given. It is time for the principles of staging to be widely debated and new principles and processes to be introduced to ensure that we are not in the same situation in the future. The disparity between therapeutic decision making and TNM staging is marked and we would appeal for the radical overhaul of TNM staging to make it fit for the twenty-first century. TNM is central to the management of cancer patients and we must protect and enhance its reputation.

Entities:  

Mesh:

Year:  2010        PMID: 20593493     DOI: 10.1002/path.2720

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

Review 1.  Has the new TNM classification for colorectal cancer improved care?

Authors:  Iris D Nagtegaal; Phil Quirke; Hans-Joachim Schmoll
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

Review 2.  EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review.

Authors:  P Quirke; N P West; I D Nagtegaal
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

3.  Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma.

Authors:  Jonathan B Rock; M Kay Washington; N Volkan Adsay; Joel K Greenson; Elizabeth A Montgomery; Marie E Robert; Rhonda K Yantiss; Amy M Lehman; Wendy L Frankel
Journal:  Arch Pathol Lab Med       Date:  2013-07-31       Impact factor: 5.534

4.  Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer.

Authors:  Monirath Hav; Louis Libbrecht; Karen Geboes; Liesbeth Ferdinande; Tom Boterberg; Wim Ceelen; Piet Pattyn; Claude Cuvelier
Journal:  Virchows Arch       Date:  2015-02-19       Impact factor: 4.064

Review 5.  Neo-adjuvant radiotherapy in rectal cancer.

Authors:  Bengt Glimelius
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

6.  Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer.

Authors:  T D Reid; L N Sanyaolu; D Chan; G T Williams; W G Lewis
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

7.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15

8.  Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.

Authors:  Bengt Glimelius
Journal:  Ups J Med Sci       Date:  2012-05       Impact factor: 2.384

Review 9.  Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications.

Authors:  Monirath Hav; Louis Libbrecht; Liesbeth Ferdinande; Karen Geboes; Piet Pattyn; Claude A Cuvelier
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

10.  Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms.

Authors:  Colin J R Stewart; Simon Hillery; Cameron Platell; Giacomo Puppa
Journal:  Cancers (Basel)       Date:  2011-01-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.